Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea

PURPOSE: Epidermal growth factor receptor (EGFR) exon 20 insertion mutations account for approximately 4% of all EGFR mutations. Given the rarity of this mutation, its clinical outcomes are not fully established. MATERIALS AND METHODS: Between 2009 and 2017, non-small cell lung cancer (NSCLC) patien...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Res Treat
Hlavní autoři: Byeon, Seonggyu, Kim, Youjin, Lim, Sung Won, Cho, Jang Ho, Park, Sehoon, Lee, Jiyun, Sun, Jong-Mu, Choi, Yoon-La, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Cancer Association 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6473281/
https://ncbi.nlm.nih.gov/pubmed/30049203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2018.151
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky